SCHEMBL265392

SCHEMBL265392

CC(=O)Nc1cccc(Br)c1C

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
HPGD P15428 2/20 0.55
RXFP1 Q9HBX9 1/20 0.51
POLB P06746 2/20 0.45
LMNA P02545 1/20 0.45
MAOA P21397 1/20 0.45
KDM4E B2RXH2 3/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
GAA P10253 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17495017 0.86 NPC1 (0.46) ALDH1A1POLBLMNAKDM4EHSD17B10
SCHEMBL14817806 0.86 ALDH1A1 (0.65) ALDH1A1HPGDPOLBLMNAMAOA
SCHEMBL6694336 0.82 RXFP1 (0.53) ALDH1A1HPGDRXFP1POLBMAOA
SCHEMBL1601224 0.82 RXFP1 (0.58) ALDH1A1HPGDRXFP1POLBKDM4E
SCHEMBL29408737 0.82 RXFP1 (0.61) ALDH1A1HPGDRXFP1POLBLMNA
SCHEMBL422636 0.82 RXFP1 (0.61) ALDH1A1HPGDRXFP1POLBLMNA
SCHEMBL23705971 0.81 RXFP1 (0.51) ALDH1A1HPGDRXFP1POLBMAOA
SCHEMBL2307143 0.80 ALDH1A1 (0.70) ALDH1A1HPGDPOLBLMNAHSD17B10
SCHEMBL30702637 0.80 ALDH1A1 (0.70) ALDH1A1HPGDPOLBLMNAHSD17B10
SCHEMBL146375 0.79 RXFP1 (0.50) ALDH1A1HPGDRXFP1POLBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-10-24 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores OREGON HEALTH & SCIENCE UNIVERSITY (US) 2024-07-09 US disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
EP-3849496-B1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES UNIV OREGON HEALTH & SCIENCE (US) 2023-10-25 EP disclosed
CN-112804982-B Near infrared nerve-retaining benzo [ c ] phenoxazine fluorophores 俄勒冈健康与科学大学 2023-07-25 CN disclosed
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2022-02-10 US disclosed
EP-3643308-B1 COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF CSTONE PHARMACEUTICALS (KY) 2021-05-19 EP disclosed
CN-112804982-A Benzo [ c ] phenoxazine fluorophores for near-infrared nerve retention 俄勒冈健康与科学大学 2021-05-14 CN disclosed
US-7528143-B2 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2009-05-05 US disclosed
US-7528143-B2 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2009-05-05 US disclosed
CN-101370792-A Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN INC (US) 2009-02-18 CN disclosed
US-20070259904-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-11-08 US disclosed
US-20070259904-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-11-08 US disclosed
US-20070259904-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-11-08 US disclosed
US-20070191405-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-08-16 US disclosed
US-20070191405-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-08-16 US disclosed
US-20070191405-A1 Bi-aryl meta-pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2007-08-16 US disclosed
WO-2007053452-A1 BI-ARYL META-PYRIMIDINE INHIBITORS OF KINASES TARGEGEN, INC. (US) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191405-A1 Bi-aryl meta-pyrimidine inhibitors of kinases JAK2, TYK2, JAK3 ALDH1A1 3235/4885HPGD 3352/4885RXFP1 4101/4885
US-20240352035-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 ALDH1A1 1034/4885HPGD 855/4885RXFP1 789/4885
US-20070259904-A1 Bi-aryl meta-pyrimidine inhibitors of kinases JAK2, TYK2, JAK3 ALDH1A1 3235/4885HPGD 3352/4885RXFP1 4101/4885
US-12030893-B2 Near-infrared nerve-sparing benzo[c]phenoxazine fluorophores NTRK1, PMP22, PAX3 ALDH1A1 1034/4885HPGD 855/4885RXFP1 789/4885
US-20220041619-A1 NEAR-INFRARED NERVE-SPARING BENZO[C]PHENOXAZINE FLUOROPHORES NTRK1, PMP22, PAX3 ALDH1A1 1034/4885HPGD 855/4885RXFP1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.